期刊文献+

中药复方干预抗结核化疗致肝损伤疗效的系统评价 被引量:7

Systematic Evaluation on the Effect of Chinese Medicine Formula on the Intervention of Liver Injury Induced by Anti-Tuberculosis Chemotherapy
下载PDF
导出
摘要 目的系统评价中药复方干预抗结核化疗致肝损伤的有效性。方法计算机检索中国知网、维普期刊数据库、万方数据和Pub Med数据库,搜集中药复方干预抗结核化疗致肝损伤的随机对照试验(RCT),检索时限均为建库至2019年3月1日。由2名研究者独立筛选文献、提取资料并评价纳入研究的偏倚风险后,采用RevMan 5.3软件进行Meta分析。结果共纳入17个RCT,共计1 410位抗结核化疗致肝损伤患者。Meta分析结果提示:与常规保肝治疗比较,中药复方干预抗结核化疗致肝损伤的有效率[RR=1.83,95%CI(1.50,2.23),P<0.01]、血清谷丙转氨酶(ALT)[MD=-50.38,95%CI(-54.17,-46.58),P<0.01]、谷草转氨酶(AST)[MD=-61.65,95%CI(-72.68,-50.61),P<0.01]、总胆红素(TBiL)[MD=-11.02,95%CI(-13.24,-8.79),P<0.01]均优于对照组。结论中药复方更有利于减轻和控制抗结核化疗过程中肝损伤的发生,对保证结核病人规律服药,控制病情、完成抗结核治疗方案具有重要的意义。 OBJECTIVE To systematically evaluate the efficacy of Chinese medicine formula in the intervention of liver injury induced by anti-tuberculosis chemotherapy.METHODS CNKI,VIP,Wanfang Data and Pub Med databases were searched to collect randomized controlled trial(RCT)of Chinese medicine formula in intervention of liver injury induced by anti-tuberculosis chemotherapy from inception to the first of March 1,2019.Two reviewers independently screened literature,extracted data and assessed the risk of bias of included studies.Meta-analysis was then performed by RevMan 5.3 software.RESULTS A total of 17 RCTs involving 1 410 patients with liver injury caused by anti-tuberculosis chemotherapy were included.The results showed that compared to the conventional treatment to protecting liver,intervention with Chinese medicine formula could significantly improve the effective rate [RR=1.83,95%CI(1.50,2.23),P<0.01],and its serum glutamic pyruvic transaminase(ALT)[MD=-50.38,95%CI(-54.17,-46.58),P<0.01],glutamic oxalacetic transaminase(AST)[MD=-61.65,95%CI(-72.68,-50.61),P<0.01],and total bilirubin(TBiL)[MD=-11.02,95%CI(-13.24,-8.79),P<0.01]were all better.CONCLUSION Current evidence shows that Chinese medicine formula is more conducive to reduce and control the occurrence of liver injury in the course of anti-tuberculosis treatment.It is of great significance to ensure that tuberculosis patients take drugs regularly,control their condition and complete the anti-tuberculosis treatment program.
作者 施铮 陈仁寿 韩江 池志恒 朱巳旲 SHI Zheng;CHEN Ren-shou;HAN Jiang;CHI Zhi-heng;ZHU Si-tai(TCM Cultural Literature,Nanjing University of ChinesE-Medicine,Nanjing,210023,China;School of Traditional ChinesE-Medicine,Beijing University of ChinesE-Medicine,Beijing,100029,China)
出处 《南京中医药大学学报》 CAS CSCD 北大核心 2020年第1期110-115,共6页 Journal of Nanjing University of Traditional Chinese Medicine
基金 国家自然科学基金(81904322) 江苏省研究生科研创新计划项目(KYCX19_1246)
关键词 中药复方 结核病 药物性肝损伤 随机对照试验 系统评价 Chinese medicine formula tuberculosis drug-induced liver injury randomized controlled trial systematic review
  • 相关文献

参考文献15

二级参考文献56

共引文献30

同被引文献101

引证文献7

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部